Search

Search Constraints

You searched for: Author/Creator Abitbol, Vered

Search Results

21. Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis. Issue 3 (March 2020)

22. Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy. Issue 6 (June 2016)

23. Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study. Issue 1 (March 2023)

24. Risk of serious infection in healthcare workers with inflammatory bowel disease: a case‐control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID). Issue 7 (2nd August 2018)

25. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Issue 4 (7th December 2020)

26. Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study. Issue 4 (7th December 2020)

28. Three‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi‐centre cohort study. Issue 1 (5th June 2019)

29. Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID. (19th November 2020)

30. Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients. Issue 7 (20th February 2020)